首页> 外文期刊>Infection and immunity >Immune Responses to Mycobacterial Antigens in the Gambian Population: Implications for Vaccines and Immunodiagnostic Test Design
【24h】

Immune Responses to Mycobacterial Antigens in the Gambian Population: Implications for Vaccines and Immunodiagnostic Test Design

机译:冈比亚人群中对分枝杆菌抗原的免疫反应:对疫苗和免疫诊断测试设计的影响。

获取原文
           

摘要

Recombinant immunodominant mycobacterial antigens are needed for the development of new vaccines and immunodiagnostic tools for use against tuberculosis. Ubiquitous exposure to mycobacteria in tropical countries could influence vaccine-induced immunity and the specificity of tuberculosis immunodiagnosis. For this study conducted in The Gambia, cellular immune responses to recombinant mycobacterial antigens were characterized in Mycobacterium bovis BCG-vaccinated and nonvaccinated infants, adult community controls, household contacts, health care workers, and tuberculosis patients. Neonatal BCG vaccination induced gamma interferon (IFN-γ) responses to Mtb8.4, Mtb32-C, Mtb39A, Mtb9.9A, and Mtb32-N, but not CFP-10 (Mtb11) and α-crystallin (Mtb16). Exposure to Mycobacterium tuberculosis in household contacts and health care workers was associated with high responses to CFP-10 and α-crystallin. Generally, low IFN-γ responses were found in tuberculosis patients. These results suggest that Mtb8.4, Mtb32-C, Mtb39A, Mtb9.9A, and Mtb32-N may be used in a subunit vaccine to boost BCG-induced immunity. While CFP-10 and α-crystallin are promising candidates for the immunodiagnosis of M. tuberculosis infection or for vaccine use, disease-associated immunosuppression may prevent IFN-γ immunodiagnosis of more advanced tuberculosis.
机译:重组免疫优势分枝杆菌抗原是开发用于结核病的新疫苗和免疫诊断工具所必需的。在热带国家,无处不在的分枝杆菌接触会影响疫苗诱导的免疫和结核病免疫诊断的特异性。在冈比亚进行的这项研究中,接种了牛分枝杆菌和未接种牛的分枝杆菌牛,成年社区对照,家庭接触者,医护人员和肺结核患者对重组分枝杆菌抗原的细胞免疫反应进行了表征。新生儿BCG疫苗接种诱导了对Mtb8.4,Mtb32-C,Mtb39A,Mtb9.9A和Mtb32-N的伽马干扰素(IFN-γ)反应,但对CFP-10(Mtb11)和α-晶体蛋白(Mtb16)没有反应。家庭接触者和医护人员接触结核分枝杆菌与对CFP-10和α-结晶蛋白的高响应有关。通常,在结核病患者中发现低的IFN-γ反应。这些结果表明,Mtb8.4,Mtb32-C,Mtb39A,Mtb9.9A和Mtb32-N可用于亚单位疫苗中以增强BCG诱导的免疫力。 CFP-10和α-晶状体蛋白是 M免疫诊断的有希望的候选者。结核感染或用于疫苗,与疾病相关的免疫抑制可能会阻止IFN-γ对更晚期结核的免疫诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号